Back to Journals » Journal of Hepatocellular Carcinoma » Volume 12 » default

ISSN: 2253-5969


Archive: Volume 12, 2025

Prognostic Value of Gd-BOPTA Enhanced MRI in Solitary Resected Hepatocellular Carcinoma Without Microvascular Invasion

Zhang J, Luo H, Li Y, Feng Y, Pan X, Ouyang B, Nian G, Jia N, Li Y

Journal of Hepatocellular Carcinoma 2025, 12:1471-1482

Published Date: 18 July 2025

Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma

Zhang J, Xu Y, Ni X, Mao Z, Xiao H, Chen M, Lin Y, Pan J, Zhang B, Zhang L, Zheng X, Song G, Ge N

Journal of Hepatocellular Carcinoma 2025, 12:1453-1469

Published Date: 17 July 2025

A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030

Lau-Min KS, Abrams T, Bullock A, Kaplan A, Salas Karnes L, Kennedy MW, LeBedis CA, Lin MV, McCleary NJ, Sioshansi S, Voligny E, Walsh EP, Manz CR

Journal of Hepatocellular Carcinoma 2025, 12:1417-1424

Published Date: 16 July 2025

Silencing NEDD4L Effectively Inhibits the Malignant Behaviors of Hepatocellular Carcinoma

Dai J, Zhu T, Wan J, Liu R, Song Y, Zhang D, Wang X, Zhang H, Li W, Lin J, Zhu X, Liu Y

Journal of Hepatocellular Carcinoma 2025, 12:1369-1391

Published Date: 10 July 2025

Hsa_circ_0007991 Promotes Immune Evasion in Hepatocellular Carcinoma via Regulation of the miR-505-3p/CANX Axis

Wang L, Liang L, Qian J, Yu C, Shi Y, Yan X, Chen X

Journal of Hepatocellular Carcinoma 2025, 12:1337-1351

Published Date: 7 July 2025

Multidisciplinary Team Management of Hepatocellular Carcinoma in the MENA Region: Current Practices, Challenges, and Gaps

El-Kassas M, Khalifa R, AlNaamani KM, Shousha H, Yilmaz Y, Sanai FM, Almattooq M, Labidi A, Akroush MWI, Debzi N, Abdelmalek MO, Abdeen NS, Tumi A, Elbadry M, El Fouly A, Marwan E, Al Suwaidi J, Elzouki AN, Alswat KA

Journal of Hepatocellular Carcinoma 2025, 12:1315-1335

Published Date: 8 July 2025

Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study

Yang ZL, Gan YX, Xu JX, Tang YH, Ouyang LY, Qi LN, Xu L

Journal of Hepatocellular Carcinoma 2025, 12:1301-1314

Published Date: 5 July 2025

Integrating CEUS Imaging Features and LI-RADS Classification for Postoperative Early Recurrence Prediction in Solitary Hepatocellular Carcinoma: A Machine Learning-Based Prognostic Approach

Liang L, Pang J, Zhang B, Que Q, Gao R, Wu Y, Peng J, Zhang W, Bai X, Wen R, He Y, Yang H

Journal of Hepatocellular Carcinoma 2025, 12:1287-1300

Published Date: 3 July 2025

Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study

Barbe-Richaud JB, Moinard-Butot F, Husson-Wetzel S, Bolliet M, Chiappa P, Belletier C, Ribeiro M, Poprawa E, Bigot C, Abergel A, Ben Abdelghani M

Journal of Hepatocellular Carcinoma 2025, 12:1279-1286

Published Date: 1 July 2025

Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study

Liu X, Zhuang L, Yang F, Liu P, Xia Z, Guo Y, Dong P, Chen C, Li Z

Journal of Hepatocellular Carcinoma 2025, 12:1241-1252

Published Date: 27 June 2025

Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma

Chen PY, Chang CK, Chen BB, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2025, 12:1221-1229

Published Date: 23 June 2025

Application of Robotic Surgery in Hepatocellular Carcinoma

Li PH, Ding ZW, Ye YQ

Journal of Hepatocellular Carcinoma 2025, 12:1217-1220

Published Date: 19 June 2025

In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma

Liang JD, Liang PC, Shun CT, Chen CH, Wu YM, Hsu YC, Lee YT, Yang PM, Huang GT, Salazar AM, Lee HS, Sheu JC, Weng MT

Journal of Hepatocellular Carcinoma 2025, 12:1191-1204

Published Date: 14 June 2025

Intravoxel Incoherent Motion Improves the Accuracy of Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma

Li M, Zhang G, Li J, Ren Y, Jin X, Ke Q, Guo C, Lv J, Lu H, Xu Y, Liang W, Quan X, Li X

Journal of Hepatocellular Carcinoma 2025, 12:1177-1190

Published Date: 11 June 2025

Genetic Variants of UGP2 and FBP2 in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma

Gong R, Qiu M, Liu Y, Cao J, Zhou Z, Lin Q, Jiang Y, Liang X, Wei Y, Wen Q, Chen P, Wei X, Wei J, Zhan S, Zhang R, Ye D, Yu H

Journal of Hepatocellular Carcinoma 2025, 12:1155-1166

Published Date: 7 June 2025

Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy

Liu SW, Zhou Y, Feng XY, Hai L, Ma WL, Ma LN, Ding XC, Luo X

Journal of Hepatocellular Carcinoma 2025, 12:1141-1154

Published Date: 5 June 2025

Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning

Yao F, Miao J, Quan B, Li J, Tang B, Lu S, Yin X

Journal of Hepatocellular Carcinoma 2025, 12:1111-1128

Published Date: 31 May 2025

Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma

Song Z, Zheng X, Wang H, Dong D, Zhu X, Geng J, Li S, Song M, Du R, Zhang Y, Liu Z, Cai Y, Li Y, Wang W

Journal of Hepatocellular Carcinoma 2025, 12:1097-1110

Published Date: 31 May 2025

Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis

Fu X, Jiang S, Li Y, Guo Y, Gong B, Lou J, Li Y, Wang S, Sun Y, Ren Y, Chen Q, Yang L

Journal of Hepatocellular Carcinoma 2025, 12:1069-1082

Published Date: 30 May 2025

Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study

Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J

Journal of Hepatocellular Carcinoma 2025, 12:1043-1056

Published Date: 22 May 2025

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients

Liu CW, Lin PT, Teng W, Chen WT, Su CW, Hsieh YC, Lin CC, Lin CY, Lin SM

Journal of Hepatocellular Carcinoma 2025, 12:1017-1029

Published Date: 21 May 2025

Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study

Su K, Liu X, Zeng YC, Xu J, Li H, Wang H, Du S, Wang H, Yue J, Yin Y, Li Z

Journal of Hepatocellular Carcinoma 2025, 12:933-947

Published Date: 9 May 2025

Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population

Chen HK, Chang KC, Shao SC, Soong RS, Chen YC, Wu CF, Wu TH, Chou TS, Chan SC, Lai ECC

Journal of Hepatocellular Carcinoma 2025, 12:879-890

Published Date: 7 May 2025

Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis

Munker S, Rodriguez I, Bernhart K, Ben Khaled N, Findik M, Siegmund LK, Ye L, Reiter FP, Roessler D, Nasseh D, Balcar L, Pomej K, Scheiner B, Weiss C, Pinter M, Seidensticker M, Mayerle J, Philipp AB, De Toni EN

Journal of Hepatocellular Carcinoma 2025, 12:855-864

Published Date: 5 May 2025

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling

Wang Y, Tan H, Wen C, Chen S, Zheng G, Qi H, Xie L, Shen L, Cao F, Fan W

Journal of Hepatocellular Carcinoma 2025, 12:825-835

Published Date: 26 April 2025

A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma

Zhang Z, Zhao H, Wang P, Geng X, Yin M, Liu Y, Zhang S, Liang Y, Ji J, Zheng G

Journal of Hepatocellular Carcinoma 2025, 12:805-823

Published Date: 18 April 2025

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network

Cosgrove D, Tan R, Osterland AJ, Hernandez S, Ogale S, Mahrus S, Murphy J, Wilson T, Patton G, Loaiza-Bonilla A, Singal AG

Journal of Hepatocellular Carcinoma 2025, 12:791-804

Published Date: 18 April 2025

Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit

Wu M, Zou F, He S, Pi Y, Song Y, Chen S, Li L

Journal of Hepatocellular Carcinoma 2025, 12:729-745

Published Date: 13 April 2025

Preoperative Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics

Li Y, Duan S, Ren S, Li D, Ma Y, Bu D, Liu Y, Li X, Cai X, Zhang L

Journal of Hepatocellular Carcinoma 2025, 12:715-727

Published Date: 12 April 2025

Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning

Liu Q, Yang Y, Wang Y, Wei S, Yang L, Liu T, Yu Z, Feng Y, Yao P, Zhu Q

Journal of Hepatocellular Carcinoma 2025, 12:685-704

Published Date: 5 April 2025

ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab

Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D’Alessio A

Journal of Hepatocellular Carcinoma 2025, 12:671-683

Published Date: 4 April 2025

Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B

Wu T, Yan J, Xiong F, Liu X, Zhou Y, Ji X, Meng P, Jiang Y, Hou Y

Journal of Hepatocellular Carcinoma 2025, 12:659-670

Published Date: 3 April 2025

The Expression of Ferroptosis-Related Genes in Hepatocellular Carcinoma and Their Relationships With Prognosis

Li H, Hu X, Wang L, Gu X, Chen S, Tang Y, Chen Y, Chen J, Yuan Z, Wang Y

Journal of Hepatocellular Carcinoma 2025, 12:629-648

Published Date: 20 March 2025

Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score

Fan W, Zheng X, Zhang W, Zhu B, Wu Y, Xue M, Tang R, Huang Z, Qiao L, Lu M, Wu J, Tang Y, Chen J, Huang S, Bai M, Li J

Journal of Hepatocellular Carcinoma 2025, 12:615-628

Published Date: 20 March 2025

Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study

Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S

Journal of Hepatocellular Carcinoma 2025, 12:561-577

Published Date: 19 March 2025

Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience

De la Garza-Ramos C, Montazeri SA, LeGout JD, Lewis AR, Frey GT, Paz-Fumagalli R, Hallemeier CL, Rutenberg MS, Ashman JB, Toskich BB

Journal of Hepatocellular Carcinoma 2025, 12:553-559

Published Date: 13 March 2025

Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma

Zheng G, Zheng M, Hu P, Zhu Y, Zhang W, Zhang F

Journal of Hepatocellular Carcinoma 2025, 12:539-552

Published Date: 12 March 2025

The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer

Liu Y, Jiang W, Li X, Zhao H, Wang S

Journal of Hepatocellular Carcinoma 2025, 12:513-526

Published Date: 6 March 2025

Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells

Wu M, Wang H, Wu X, Zeng H, Miao M, Song Y

Journal of Hepatocellular Carcinoma 2025, 12:467-480

Published Date: 3 March 2025

Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective

Zhu XD, Zhao L, Li B, Cheng Y, Sun HC

Journal of Hepatocellular Carcinoma 2025, 12:399-413

Published Date: 26 February 2025

Application of Intravoxel Incoherent Motion in the Prediction of Intra-Tumoral Tertiary Lymphoid Structures in Hepatocellular Carcinoma

Ma L, Liao S, Zhang X, Zhou F, Geng Z, Hu J, Zhang Y, Zhang C, Meng T, Wang S, Xie C

Journal of Hepatocellular Carcinoma 2025, 12:383-398

Published Date: 22 February 2025

Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis

Lu L, Zhou X, Zheng J, Li D

Journal of Hepatocellular Carcinoma 2025, 12:367-382

Published Date: 21 February 2025

Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients

Zhu D, Tulahong A, Abuduhelili A, Liu C, Aierken A, Lin Y, Jiang T, Lin R, Shao Y, Aji T

Journal of Hepatocellular Carcinoma 2025, 12:353-365

Published Date: 19 February 2025

Outcomes and Prognostic Factors in Cirrhotic Patients with Acute Variceal Bleeding and Hepatocellular Carcinoma: A Nested Case–Control Study

Liu G, Xiao S, Xiang T, Wang X, Shen Y, Yang L, Luo X

Journal of Hepatocellular Carcinoma 2025, 12:343-352

Published Date: 19 February 2025

Comprehensive Analysis of the Role of Heat Shock Proteins in the Immune Microenvironment and Clinical Significance of Hepatocellular Carcinoma

Xiao H, Wang B, Xiong S, Li C, Ding Y, Chao D, Mei B, Shen N, Luo G

Journal of Hepatocellular Carcinoma 2025, 12:325-342

Published Date: 17 February 2025

Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma

Li Y, Lu R, Abuduhailili X, Feng Y

Journal of Hepatocellular Carcinoma 2025, 12:301-324

Published Date: 17 February 2025

Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States

Finn RS, Iyer R, Kalman RS, Parikh ND, Cabrera R, Babajanyan S, Kaseb AO

Journal of Hepatocellular Carcinoma 2025, 12:231-246

Published Date: 7 February 2025

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant

Zhang S, Song R, Hou C, Yao H, Xu J, Zhou H, Li S, Cai W, Fei Y, Meng F, Yin D, Wang J, Zhang S, Liu Y, Wang J, Liu L

Journal of Hepatocellular Carcinoma 2025, 12:219-229

Published Date: 5 February 2025

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Wang W, Zhang Q, Cui Y, Zhang S, Li B, Xia T, Song Y, Zhou S, Ye F, Xiao W, Cao K, Chi Y, Qu J, Zhou G, Chen Z, Zhang T, Chen X, Ju S, Wang YC

Journal of Hepatocellular Carcinoma 2025, 12:193-203

Published Date: 29 January 2025

The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection

Yu ZC, Fang ZK, Yu Y, Liu SY, Wang KD, Shi ZJ, Jin LM, Huang XK, Lu Y, Shen GL, Liu JW, Huang DS, Zhang CW, Liang L

Journal of Hepatocellular Carcinoma 2025, 12:183-192

Published Date: 30 January 2025

Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus

Li X, Cao K, Fu Z, Chen X, Zhong J, Liu L, Ding N, Zhang X, Qu Z, Zhu L, Zhai J

Journal of Hepatocellular Carcinoma 2025, 12:169-182

Published Date: 25 January 2025

Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma

Zhong L, Peng W, Sun J, Luo Y, Sheng H, Wu Y, Zhou T, Zhou C, Cao C

Journal of Hepatocellular Carcinoma 2025, 12:123-134

Published Date: 22 January 2025

A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma

Wei X, Guo Z, Zhang T, Liang J

Journal of Hepatocellular Carcinoma 2025, 12:107-121

Published Date: 21 January 2025

Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus

Hatia RI, Hwang LY, Li R, Troisi C, Jalal PK, Amos CI, Gomez HF, Chun YS, Rashid A, Kaseb AO, Scheet PA, Hassan MM

Journal of Hepatocellular Carcinoma 2025, 12:93-106

Published Date: 21 January 2025

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE

Wu L, Chen L, Zhang L, Liu Y, Ouyang D, Wu W, Lei Y, Han P, Zhao H, Zheng C

Journal of Hepatocellular Carcinoma 2025, 12:77-91

Published Date: 21 January 2025

Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma

Song Y, Tian S, Li Z, Miao J, Wu M, Xu T, Wu X, Qiao J, Zhang X, Zhao H, Kang L, Cao L, Zhu P, Miao M

Journal of Hepatocellular Carcinoma 2025, 12:59-76

Published Date: 18 January 2025

Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy

Yang C, Chen Y, Sheng L, Wang Y, Zhang X, Yang Y, Ronot M, Jiang H, Song B

Journal of Hepatocellular Carcinoma 2025, 12:43-58

Published Date: 16 January 2025

Fully Covered Stent-TIPS for Advanced HCC Patients with Portal Vein Tumor Thrombus-Related Severe Symptomatic Portal Hypertension

Liu Z, Lyu T, Yang J, Xie Y, Fan S, Song L, Zou Y, Wang J

Journal of Hepatocellular Carcinoma 2025, 12:29-41

Published Date: 14 January 2025